Q3 Earnings Alert! Plan early for this week’s stock reports with all key data in 1 placeSee list

Charles River Laboratories (CRL)

NYSE
Currency in USD
Disclaimer
192.97
+1.54(+0.80%)
Closed
After Hours
191.59-1.38(-0.72%)
CRL Scorecard
Full Analysis
Analysts predict the company will be profitable this year
Fair Value
Day's Range
190.50194.74
52 wk Range
161.65275.00
Prev. Close
191.43
Open
191.29
Day's Range
190.5-194.74
52 wk Range
161.65-275
Volume
365,646
Average Volume (3m)
720,123
1-Year Change
1.02%
Book Value / Share
Unlock
Fair Value
Unlock
Fair Value Upside
Unlock
CRL Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
216.95
Upside
+12.43%
Members' Sentiments
Bearish
Bullish
ProTips
Profitable over the last twelve months
Show more

Charles River Laboratories Company Profile

Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening pre-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of preclinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. This segment also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies. It also provides contract vivarium operation services to biopharmaceutical clients. The company was founded in 1947 and is headquartered in Wilmington, Massachusetts.

Compare CRL to Peers and Sector

Metrics to compare
CRL
Peers
Sector
Relationship
P/E Ratio
23.1x25.6x−0.6x
PEG Ratio
−2.000.000.00
Price/Book
2.7x2.9x2.6x
Price / LTM Sales
2.4x4.6x3.2x
Upside (Analyst Target)
8.8%20.0%44.2%
Fair Value Upside
Unlock9.0%7.9%Unlock

People Also Watch

103.50
ZBH
+0.66%
82.49
DG
+0.06%
87.96
TXT
+1.86%
173.59
GNRC
+4.37%

FAQ

What Is the Charles River Laboratories (CRL) Stock Price Today?

The Charles River Laboratories stock price today is 192.97

What Stock Exchange Does Charles River Laboratories Trade On?

Charles River Laboratories is listed and trades on the NYSE stock exchange.

What Is the Stock Symbol for Charles River Laboratories?

The stock symbol for Charles River Laboratories is "CRL."

What Is the Charles River Laboratories Market Cap?

As of today, Charles River Laboratories market cap is 9.96B.

What is Charles River Laboratories Earnings Per Share?

The Charles River Laboratories EPS is 8.40.

What Is the Next Charles River Laboratories Earnings Date?

Charles River Laboratories will release its next earnings report on 29 Oct 2024.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.